NCT04822181semaglutidesteatohepatitisliver fibrosis
… for its potential to treat MASH in the ongoing ESSENCE trial ( NCT04822181).Methods ESSENCE, a phase 3 trial involving 1200 participants w…
5,089articles mentioning funders
9,137funder mentions
3,238distinct funders extracted
0%of mentions human-reviewed
All extracted funders
Showing 1,561–1,620 of 3,238, ordered by supporting articles. Choose a funder to see its evidence.
InnoHK Initiative1Innovation Fund of the Federal Joint Committee of Germany1Innovation and Technology Fund1Instiglio1Institute for Safe Medication Practices1Institute of Medicine1Institutional Animal Care and Use Committee1Institutional Ethical Review Committee1Institutional Research Ethics Committee1Integrated Public Use Microdata Series1Intensive Care Society1Inter-American Development Bank1Internal Medicine Service1Internal funding1International Association for Trauma Surgery and Intensive Care1International Association of Diabetes and Pregnancy Study Groups1International Cancer Benchmarking Partnership1International Cartilage Regeneration & Joint Preservation Society1International Clinical Trial Registry Platform1International Clinical Trials Registry Platform1International Council for Harmonisation1International Development Association1International Developmental Pediatrics Association1International Federation of Clinical Chemistry and Laboratory Medicine1International Federation of Red Cross and Red Crescent Societies1International Federation of Sports Physical Therapy1International Holocaust Remembrance Alliance1International Labour Organisation1International Medical Device Regulators1International Organisation for Standardisation1International Organization for Migration1International Organization for Standardization1International Paediatric Stroke Organization Executive Committee1International Parkinson and Movement Disorders Society1International Pediatric Association1International Pharmaceutical Abstracts1International Pharmaceutical Federation1International Prehabilitation and Perioperative Exercise Testing Society1International Radiosurgery Research Foundation1International Rescue Committee1International Tobacco Control Four Country Smoking and Vaping Survey1Iovance Biotherapeutics1Iran Health Insurance Organization1Italian Society of Infectious and Tropical Diseases1JAMA 20251JAMA Intern Med 20251JAMA Network1JEP-2025-6251JGSDF1JGW Patterson Foundation1JIPMER Institutional Ethics Committee1JMDC Inc1JNJ Medtech1JP Morgan1James Lind Alliance Priority Setting Partnership1Jaminan Kesehatan Nasional1Japan Agency for Medical Research and Development1Japanese Long-Term Care Insurance system1Jazz Pharmaceuticals1Joint British Diabetes Societies1
Articles mentioning funders
5,089 articles · page 369 of 425NHSchronic liver disease (CLD)Metabolic dysfunction-associated steatotic liver disease (MASLD)MASLD
…ancet commission prioritises earlier diagnosis of fibrosis with NHS community pilots underway. We aimed to evaluate the performance…
NCT04526665PBCElafibranor
…s are common symptoms in PBC. In the phase III ELATIVE® trial ( NCT04526665), elafibranor significantly improved biomarkers of cholestasis …
NCT04526665osteoporosisPBCelafibranorosteopenia
…iomarkers assessed to Week 52 in the phase III ELATIVE® trial ( NCT04526665).Patients (N=161) were randomized 2:1 to elafibranor 80 mg or p…
NCT04526665ElafibranorPBCFibrosis
…LF]) and biochemical markers in patients with PBC in ELATIVE® ( NCT04526665) to Week 104; NITs are also stratified by disease stage.Proport…
National Institute for Health and Care Excellenceliver cancerAFPPBCAIHSwansea Bay University Health Boardliver diseaseHCCPSCcurative treatment+2 more
…st risk to develop HCC, British Society of Gastroenterology and National Institute for Health and Care Excellence guidelines recommend 6-monthly US surveillance with/without AFP…
TrustsHepatocellular carcinomahepatitis BcirrhosisHCCcurative treatmentEuropean Association for the Study of the Liver
… the development of standardised HCC surveillance strategies in Trusts, with dedicated surveillance databases now being created, in ad…
AASLDRifaximinLactulosehepatic encephalopathychronic liver diseaseLOLAliver cirrhosis
…se. 1 The American Association for the Study of Liver Diseases (AASLD) makes a recommendation for IV L-ornithine L-Aspartate (LOLA) t…
TrustDecompensated liver cirrhosisCirrhoSIMhepatic encephalopathydecompensated cirrhosisAcute-on-chronic liver failurespontaneous bacterial peritonitisACLFvariceal bleeding
…rdise early interventions and improve cirrhosis management, our Trust adapted the British Society of Gastroenterology evidence-based …
SLaMceruloplasminCpSouth London and Maudsley NHS Foundation TrustWDSLaMWilson diseaseWilson’s disease
…tric assessment.South London and Maudsley NHS Foundation Trust (SLaM) is an international leader in mental health and is the largest…
Ethics Review Boardbreast cancerKyoto University Central Institutional Review Boardbreast reconstructionJapanese Society of Breast Oncoplastic Surgery
…mission for performance of the study has been obtained from the Ethics Review Board at each participating centre. We plan to disseminate the findin…
EU-trial-number 2023-510186-98VTEMedical Research Ethics Committee Leiden-Den Haag-Delft
…by the Medical Research Ethics Committee Leiden-Den Haag-Delft, EU-trial-number 2023-510186-98. Study results will be disseminated through peer-reviewed journ…